Karachi, Abbott Laboratories (Pakistan) Ltd. (ABOT) has reported an earnings per share (EPS) of 30.69 for the fiscal year ending in December 2022, with a declared dividend of 150%. The healthcare giant, established in 1982, saw its shares trading between 514 and 399.99, achieving a turnover of 802,100 units. With a paid-up capital of Rs. 979 million, Abbott Laboratories continues to dominate the pharmaceutical sector with robust financial health.
Check Also
DPM Emphasizes FDI-Led Economic Growth Strategy
Islamabad: Deputy Prime Minister Ishaq Dar has emphasized the government's policy to invite Foreign Direct Investment in Pakistan, which is undertaken to promote economic and commercial activities in the country. He was chairing a meeting of the Cabin...
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service